Related references
Note: Only part of the references are listed.PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke
Ranjeet K. Sinha et al.
BLOOD (2018)
Mechanisms coupling thrombin to metastasis and tumorigenesis
Allison S. Remiker et al.
THROMBOSIS RESEARCH (2018)
Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years
Gry S. Haaland et al.
JAMA INTERNAL MEDICINE (2017)
PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo
R. Auvergne et al.
ONCOGENE (2016)
Protease-activated receptors (PARs)-biology and role in cancer invasion and metastasis
Marek Z. Wojtukiewicz et al.
CANCER AND METASTASIS REVIEWS (2015)
Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen
Gregory N. Adams et al.
CANCER RESEARCH (2015)
Review of vorapaxar for the prevention of atherothrombotic events
Amy Wang
EXPERT OPINION ON PHARMACOTHERAPY (2015)
PH motifs in PAR1&2 endow breast cancer growth
A. Kancharla et al.
NATURE COMMUNICATIONS (2015)
Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer
Mohammad Jaber et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance
Karla C. S. Queiroz et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Prognostic value of matrix metalloprotease-1/protease-activated receptor-1 axis in patients with prostate cancer
Jian Wang et al.
MEDICAL ONCOLOGY (2014)
Altered Protease-Activated Receptor-1 Expression and Signaling in a Malignant Pleural Mesothelioma Cell Line, NCI-H28, with Homozygous Deletion of the β-Catenin Gene
Alessandra Fazzini et al.
PLOS ONE (2014)
Biased signaling of protease-activated receptors
Peishen Zhao et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Neutrophil Elastase and Proteinase-3 Trigger G Protein-biased Signaling through Proteinase-activated Receptor-1 (PAR1)
Koichiro Mihara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway
E. A. M. Bouwens et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46
Laurent O. Mosnier et al.
BLOOD (2012)
Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer
Jaroslaw Cisowski et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Long-term use of vitamin K antagonists and incidence of cancer: a population-based study
Vittorio Pengo et al.
BLOOD (2011)
PAR1 Plays a Role in Epithelial Malignancies: Transcriptional Regulation and Novel Signaling Pathway
Rachel Bar-Shavit et al.
IUBMB LIFE (2011)
Serine and Metalloprotease Signaling Through PAR1 in Arterial Thrombosis and Vascular Injury
Georgios Koukos et al.
IUBMB LIFE (2011)
Structure, function and pathophysiology of protease activated receptors
Mark N. Adams et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype
Gabriel J. Villares et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells
Katrin J. Svensson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis
Troy A. McEachron et al.
BLOOD (2010)
Etk/Bmx Regulates Proteinase-Activated-Receptor1 (PAR1) in Breast Cancer Invasion: Signaling Partners, Hierarchy and Physiological Significance
Irit Cohen et al.
PLOS ONE (2010)
Leukocyte Elastase Induces Lung Epithelial Apoptosis via a PAR-1-, NF-κB-, and p53-Dependent Pathway
Tomoko Suzuki et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis
Eric Yang et al.
CANCER RESEARCH (2009)
Thrombin Induces Tumor Cell Cycle Activation and Spontaneous Growth by Down-Regulation of p27Kip1, in Association with the Up-Regulation of Skp2 and MiR-222
Liang Hu et al.
CANCER RESEARCH (2009)
Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer
Teresa Chiaverotti et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNA
Gabriel J. Villares et al.
CANCER RESEARCH (2008)
Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice
Henri H. Versteeg et al.
CANCER RESEARCH (2008)
Thrombin receptor expression is upregulated in prostate cancer
V Kaushal et al.
PROSTATE (2006)
Role and regulation of the thrombin receptor (PAR-1) in human melanoma
C Tellez et al.
ONCOGENE (2003)
Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells
D Darmoul et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation
YJ Yin et al.
FASEB JOURNAL (2003)
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism
S Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
